ArticleGenome biology2026
Full-DIA enables complete single-cell proteomics from diaPASEF using deep learning.
Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Full-DIA enables complete single-cell proteomics from diaPASEF using deep learning.Genome biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
diaPASEF improves ion utilization and sensitivity by synchronizing quadrupole isolation with trapped ion mobility separation, making it suitable for single-cell proteomics. We present Full-DIA, a deep learning-driven software that enhances proteome coverage, quantitative accuracy, and analysis speed over DIA-NN for single-cell diaPASEF data. Notably, Full-DIA generates a missing-value-free protein matrix under stringent global FDR control, enabling downstream analyses without data gaps. Applied to LPS-treated and cell-cycle datasets, this matrix yields pathway enrichment results with fewer off-target and more biologically relevant pathways. Full-DIA highlights the potential of deep learning for four-dimensional diaPASEF analysis and offers a solution to missing values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.